1.Survey on the job satisfaction among the staff in the dilution situation of the hospital staffing management
Manru YANG ; Zhiwei WANG ; Yan YANG ; Li SHA ; Tong ZHAO ; Minmin YAN ; Qiyu ZOU
International Journal of Traditional Chinese Medicine 2017;39(1):1-4
To explore the status of the job satisfaction of the authorized and contract staff in a university affiliated hospital in the dilution situation of the hospital staffing management, and to discuss the key factors and reasons affecting the satisfaction difference. The questionnaire was developed based on Minnesota Satisfaction short form with extra items covering “the comprehensive satisfaction evaluation”. According to the hospital population of staff, the cluster random sampling method was used, and survey was conducted on the spot. Both authorized staff and the contract staff showed high degree of satisfaction. But the contract staff showed higher degree of satisfaction of leadership and their own responsibility sense than the authorized staff. The contract female staff showed higher degree of overall satisfaction than the authorized female staff. The discussion based on the results showed that new human resource management mode, new mechanism of flexible management of staff, targeted staff with targeted management.
2.To explore the medical cooperation between Beijing and Hebei area of traditional Chinese medicine hospitals under the background of integration of the Beijing-Tianjin-Hebei
Li SHA ; Yan YANG ; Tong ZHAO ; Manru YANG ; Minmin YAN ; Qiyu ZOU ; Zhiwei WANG
International Journal of Traditional Chinese Medicine 2016;38(8):673-676
To explore the patterns and ideas of medical cooperation between Beijing and Hebei Chinese Medicine hospitals under the background of the integration of Beijing-Tianjin-Hebei regions. By searching the 2015 China statistical yearbook for health, a survey was conducted among doctors and patients in a Hebei hospital, which is cooperate with the Beijing hospital. We found that Beijing-Tianjin regional medical resources were imbalanced, and Hebei medical resources were insufficient, and patients and doctors were satisfied with the cooperation. There are still some difficulties in Chinese medicine hospital of Beijing and Tianjin cooperation, and many departments need to work together to promote Beijing-Tianjin-Hebei rational allocation of medical resources.
3.Analysis on medicare reimbursement of traditional Chinese medicine therapies in the selected traditional Chinese medicine hospitals among national public hospital reform projects
Jinyu ZHANG ; Zhiwei WANG ; Haiyue ZHANG ; Manru YANG ; Tong ZHAO ; Li SHA
International Journal of Traditional Chinese Medicine 2015;37(12):1118-1120
Objective To find out the general status about the traditional Chinese medicine therapies that were included into medicare among the selected hospitals in the country's public hospital reform project, and to investigate the reasons for those not included and make recommendations.Methods Collecting relevant information through questionnaires, experts interviews and discussions.Results There are still some TCM therapies not included into the range of reimbursement.Most Of them are external treatment of traditional Chinese medicine, acupuncture, massage, special treatments of traditional Chinese medicine and comprehensive therapies of TCM.Conclusions The establishment of negotiations department about medicare in the field of traditional Chinese medicine was needed.Medicare should be in favor of TCM therapies, and traditional Chinese medicine hospitals should strengthen training of personnel and hiring.At the same time, a reasonable increase of the proportion of TCM experts involved in the making health insurance directory was needed.
4.Preventive effect of Polygonum Multiflorum on deteriorated micro-structure and biomechanical properties induced by prednisone
Manru ZHOU ; Jin LI ; Jingkai WU ; Xiaobin ZENG ; Jingfeng CHEN ; Liao CUI ; Yuyu LIU
Chinese Pharmacological Bulletin 2015;(9):1273-1279
Aim To investigate the preventive effect of Polygonum Multiflorum (PM)on the deteriorated mi-cro-structure and biomechanical properties induced by prednisone.Methods Ninety 6-month-old male Sprague-Dawley rats were randomly divided into nine groups,which were control,prednisone,CAL,30%ethanol eluent of the PM(H,M,L),PM(H,M,L). Prednisone was gavaged to rat for 21 weeks as model group of osteoporosis.Meanwhile,tested herbal ab-stract were orally administrated to the modeled rats in-duced by prednisone.At the end of the experiment, the right femur was collected for micro-CT scanning, three-dimensional reconstruction and biomechanical test.Results Compared with the control group,mod-el group showed destruction of bone microarchitecture, BV /TV fell 28.6%(P <0.05),bone biomechanical parameters decreases,and stiffness fell 29.7%(P <0.01 ). Compared with the model group, positive group had significantly improved effect on bone micro-architecture,and biomechanical parameters,BV /TV increased 46.7%(P <0.01 ),and stiffness increased 25.9%(P <0.01 ).30% ethanol eluent of the PM (M,L)dose may improve bone microstructure by in-creasing BV /TV 46.7% (P <0.01 ),40.0% (P <0.05)respectively,PM(H)may improve the biome-chanical parameters by increasing stiffness 24.7%(P<0.05),and 30% ethanol eluent of the PM(H)and PMhigh-dose may improve the biomechanical parame-ters,but not as positive group.Conclusions Predni-sone reduces biomechanical properties of rat femur and deteriorates femoral microstructure.30% ethanol eluent of the PM(M,L)and PM(H)plays a preventive role in the changes of micro-structural and biomechanical properties by prednisone,and increases BMD,whereas other groups have no significant preventive effect.
5.Treatment of Alzheimer's Disease with Traditional Chinese Medicine Based on β-amyloid: A Review
Yanqin QU ; Jinxin CHEN ; Chengjun DONG ; Manru XU ; Yue ZHU ; Qian LI ; Yan CHEN ; Wenbin WU
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(22):231-238
The massive accumulation of β-amyloid (Aβ) in the brain is believed to be the first pathological mechanism of Alzheimer's disease (AD), and the accumulation is mainly resulted from the overproduction and dysfunction in the clearance. Extensive and in-depth research has been carried out on AD. In addition to the drugs which are commonly used in clinical settings to improve cognitive function, Aβ monoclonal antibody aducanumab (Aduhelm) has been successfully marketed in the US, which may delay the progress of AD. Thus, it is a potential method for the treatment of AD to target Aβ, but it is expensive, with many adverse reactions and contraindications, which hinders the clinical promotion. Traditional Chinese medicine, featuring multiple components, multiple targets, multiple pathways, and high safety, can regulate the level of Aβ deposition in the brain, alleviate neurotoxicity, and prevent and treat AD by inhibiting the production and aggregation of Aβ and promoting the clearance in the brain. Berberine, gallic acid, osthole, scutellaria barbata flavonoids, Huannao Yicong decoction and Ditantang can promote α-secretase and inhibit the activity and expression of β- and γ-secretase, thus reducing production of Aβ. Baicalein, aloe-emodin, gallic acid, and curcumin can suppress the aggregation of Aβ, promote its depolymerization, and reduce the toxic effect of Aβ on nerve cells by interacting with the hydrophobic structure of Aβ and the H bond, salt bridge, and β-sheet that mediate the aggregation of Aβ. Curcumin and resveratrol can promote the expression of triggering receptor 2 in bone marrow cells of microglia and the migration and phagocytosis of Aβ in microglia. Bilobalide, Kaixinsan and curcumin can up-regulate the expression of encephalin-degrading enzyme and insulin degrading enzyme to promote Aβ degradation, and geniposide, dihydrotanshinone, dihydroartemisinin, and curcumin can degrade Aβ in cells by activating normal autophagy or inhibiting abnormal autophagy. Cycloastragenol, Danggui Shaoyaosan, Yizhi Fangdai formula and Linggui Zhugan decoction can promote the outflow of Aβ and inhibit the inflow of Aβ by improving the integrity and permeability of the blood-brain barrier (BBB). Yizhi Fangdai formula and Xueshuantong can promote the polarization of aquaporin 4(AQP4), allow Aβ to be cleared through the lymphatic system, and reduce the aggregation of Aβ in the brain, thereby relieving or preventing nerve cell damage and improving cognitive function. The above summary aims to provide more sufficient evidence and ideas for the clinical treatment of AD with traditional Chinese medicine.
6.Allosteric inhibition reveals SHP2-mediated tumor immunosuppression in colon cancer by single-cell transcriptomics.
Jian GAO ; Zhigui WU ; Mingxia ZHAO ; Rui ZHANG ; Manru LI ; Dongdong SUN ; Haibo CHENG ; Xianjia QI ; Yuxian SHEN ; Qiang XU ; Hongqi CHEN ; Dijun CHEN ; Yang SUN
Acta Pharmaceutica Sinica B 2022;12(1):149-166
Colorectal cancer (CRC), a malignant tumor worldwide consists of microsatellite instability (MSI) and stable (MSS) phenotypes. Although SHP2 is a hopeful target for cancer therapy, its relationship with innate immunosuppression remains elusive. To address that, single-cell RNA sequencing was performed to explore the role of SHP2 in all cell types of tumor microenvironment (TME) from murine MC38 xenografts. Intratumoral cells were found to be functionally heterogeneous and responded significantly to SHP099, a SHP2 allosteric inhibitor. The malignant evolution of tumor cells was remarkably arrested by SHP099. Mechanistically, STING-TBK1-IRF3-mediated type I interferon signaling was highly activated by SHP099 in infiltrated myeloid cells. Notably, CRC patients with MSS phenotype exhibited greater macrophage infiltration and more potent SHP2 phosphorylation in CD68+ macrophages than MSI-high phenotypes, suggesting the potential role of macrophagic SHP2 in TME. Collectively, our data reveals a mechanism of innate immunosuppression mediated by SHP2, suggesting that SHP2 is a promising target for colon cancer immunotherapy.